Buy Alnylam Pharmaceuticals Inc. Stocks - View ALNY Live Price (2026)

ALNY

TYPE Stocks

GROUP Stocks

BASE Alnylam Phar...

SECOND

<% (signals.list.current.rate).substr(0,7) %>

<% (signals.list.current.absolute).substr(0,9) %> (<% signals.list.current.percentage|toFixed:2 %>%)

MARKETS TREND

OPEN

<% (signals.list.current.openrate).substr(0,9) %>

HIGH

<% (signals.list.current.high).substr(0,9) %>

LOW

<% (signals.list.current.low).substr(0,9) %>

START TRADING

Multi Charts

Add to Watchlist

ALNY Signals

DON'T WANT TO MISS ANY SIGNAL? GO PREMIUM

ACCESS ALL FX, COMMODITIES & CRYPTO SIGNALS. GO PREMIUM

<% signal.pair %> (<% signal.rate %>) <% signal.action %>

<% signal.status %>

<% signal.analyst %>

Long Term

Entry Price

Stop Loss

Take Profit

<% signal.entryPrice %> N/A

PREMIUM ONLY

<% signal.stopLoss %> N/A

PREMIUM ONLY

<% signal.takeProfit %> N/A

PREMIUM ONLY

<% signal.comment %>

Description

<% signal.description %>

LATEST ANALYSIS

<% item.time_ago %> Ago

<% item.title %>

<% item.deltaTime %>

Full Analysis Feed

Last Updated: Jun 03, 2026 03:06:04 PM (GMT)

ALNY: Current live price is 286.08, reflecting a slight decrease of -0.02% from the previous price.

Support and Resistance Levels Current support levels are 284.25, 280.42, and 277.36, with resistance levels at 291.14, 294.20, and 298.03. The pivot point is 287.31.

Indicators Current RSI is 48.07, indicating a neutral trend. ATR stands at 0.94741, signaling moderate volatility. ADX is at 52.55, suggesting a strong trend. The MACD shows a histogram at 0.5813 with a current MACD of -1.52013, indicating downward momentum. The current EMA-5 is 286.78, which is above the SMA-5 at 286.52.

Market Sentiment With the price below the pivot point (287.31) and bearish indicators, further declines may occur.

ALNY Signals & Technical Analysis

Last Updated: <% indicators.interval.updated|date:'MMM d, y h:mm:ss a' %>

Market Trend

Strong Sell

Sell

Neutral

Buy

Strong Buy

Loading Market Trend ...

Market Sentiment

BUY: <% indicators.sentiment.buy.length %> SELL: <% indicators.sentiment.sell.length %> NEUTRAL: <% indicators.sentiment.neutral.length %>

Strong Sell

Sell

Neutral

Buy

Strong Buy

Trend Indicators

NAME

VALUE

ACTION

Bollinger Bands

UPPER: <% indicators.data[indicators.interval.active].bbands.value.upper %>

MIDDLE: <% indicators.data[indicators.interval.active].bbands.value.middle %>

LOWER: <% indicators.data[indicators.interval.active].bbands.value.lower %>

Sell

Buy

Parabolic SAR

<% indicators.data[indicators.interval.active].sar.value %>

Sell

Buy

Standard Deviation

<% indicators.data[indicators.interval.active].stddev.value %>

High Volatility

Low Volatility

Oscillators

NAME

VALUE

ACTION

RSI(14)

<% indicators.data[indicators.interval.active].rsi.value %>

Sell

Buy

MACD(12,26)

<% indicators.data[indicators.interval.active].macd.value %>

Buy

Sell

Neutral

ATR

<% indicators.data[indicators.interval.active].atr.value %>

High Volatility

Low Volatility

STOCH(9,6)

<% indicators.data[indicators.interval.active].stochastics.value %>

Buy

Sell

ADX

<% indicators.data[indicators.interval.active].adx.value %>

High Volatility

Low Volatility

Moving Averages

PERIOD

SIMPLE

EXPONENTIAL

MA5

<% indicators.data[indicators.interval.active].sma5.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema5.value %> Buy Sell

MA10

<% indicators.data[indicators.interval.active].sma10.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema10.value %> Buy Sell

MA20

<% indicators.data[indicators.interval.active].sma20.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema20.value %> Buy Sell

MA50

<% indicators.data[indicators.interval.active].sma50.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema50.value %> Buy Sell

MA100

<% indicators.data[indicators.interval.active].sma100.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema100.value %> Buy Sell

Pivot

PIVOT

CLASSIC

FIBONACCI

CAMARILLA

WOODIE

<% indicators.data[indicators.interval.active].pp.data.result.classic.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.r3 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r3 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r3 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.r3 %>

About (ALNY) Alnylam Pharmaceuticals Inc.

Company Background

Alnylam Pharmaceuticals Inc. (Symbol: ALNY) is a pioneering biotechnology firm dedicated to transforming the treatment landscape for genetically-defined diseases. Founded in 2002 and headquartered in Cambridge, Massachusetts, Alnylam specializes in RNA interference (RNAi) technology, which enables the silencing of disease-causing genes at the RNA level. This innovative approach has positioned the company as a leader in developing therapies for rare and prevalent diseases associated with genetic mutations. With a commitment to scientific excellence and patient-centric solutions, Alnylam has become synonymous with groundbreaking advancements in the field of genetic medicine.

Market Position

Alnylam Pharmaceuticals holds a prominent position in the biopharmaceutical industry, particularly within the RNAi therapeutics market. With a robust pipeline of investigational and commercial products, the company has successfully launched several therapies, including ONPATTRO® (patisiran), which was the first-ever RNAi therapy approved for the treatment of hereditary transthyretin-mediated amyloidosis. This significant milestone not only underscores Alnylam's innovative capabilities but also highlights its dedication to addressing unmet medical needs. The company continues to expand its product offerings and explore new indications, reinforcing its status as a frontrunner in biotechnology.

Key Financial Highlights

Alnylam has demonstrated strong financial performance, supported by its innovative product portfolio and strategic partnerships. As of October 2023, the company reported significant revenue growth driven by the sales of its RNAi therapeutics. Alnylam's financial stability is further enhanced by collaborations with major pharmaceutical companies, which provide both funding and shared expertise. With a strong balance sheet and a growing market presence, Alnylam is well-positioned for future growth, focusing on expanding its pipeline and advancing new therapies through clinical trials. The company remains committed to exploring additional applications of its RNAi technology, thereby solidifying its leadership in the biotechnology sector.

Check all ALNY conversion rates

How to Buy or Trade Alnylam Pharmaceuticals Inc. Stock (ALNY) with AvaTrade

Trading or investing in Alnylam Pharmaceuticals Inc. stock through AvaTrade starts with opening a verified trading account. After registration, complete the KYC verification process by submitting your ID and proof of address, then fund your account using a supported payment method such as bank transfer, debit card, or e-wallet. Once your funds reflect, log into the AvaTrade platform or mobile app and search for the ticker symbol ALNY, which represents Alnylam Pharmaceuticals Inc.. Before placing a trade, review the live Alnylam Pharmaceuticals Inc. share price, market trend, spread, leverage options, and recent market news that could impact the stock price.

The next step is deciding whether you want to buy or sell Alnylam Pharmaceuticals Inc. stock. Traders expecting the price to rise typically open a Buy position, while traders expecting weakness in the sector may open a Sell position using CFDs. Enter your preferred trade size, then apply risk management tools such as a stop-loss to limit downside exposure and a take-profit order to secure profits automatically. After confirming the trade, monitor key drivers including Alnylam Pharmaceuticals Inc. earnings reports, product or service announcements, business segment performance, revenue growth, and overall stock market sentiment. Many traders also use technical indicators such as moving averages, RSI, and support/resistance levels available on the AvaTrade platform to improve timing and trading decisions.

Related Stocks

INCY

Incyte Corporation

Industry Biotechnology

Exchange NASDAQ

BMRN

Biomarin Pharmaceutical Inc.

Industry Biotechnology

Exchange NASDAQ

MRNA

Moderna, Inc.

Industry Biotechnology

Exchange NASDAQ